Elanco Animal Health Incorporat (ELAN) Financials

ELAN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 14.4 billion 8.1 billion
2023-09-30 14.3 billion 8.2 billion
2023-06-30 15.8 billion 8.4 billion
2023-03-31 15.8 billion 8.3 billion

ELAN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 116.0 million 15.0 million
2023-09-30 165.0 million 10.0 million
2023-06-30 19.0 million 9.0 million
2023-03-31 -183.0 million 12.0 million

ELAN Net Income

No data available :(

ELAN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 352.0 million - -
2023-09-30 369.0 million - -
2023-06-30 367.0 million - -
2023-03-31 318.0 million - -

ELAN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 492.8 million
2023-09-30 492.7 million
2023-06-30 492.6 million
2023-03-31 492.8 million

ELAN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 41.0 million 79.0 million 292.0 million -
2023-09-30 33.0 million 86.0 million 313.0 million -
2023-06-30 42.0 million 81.0 million 353.0 million -
2023-03-31 38.0 million 81.0 million 327.0 million -

ELAN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.0 billion 516.0 million
2023-09-30 1.1 billion 487.0 million
2023-06-30 1.1 billion 434.0 million
2023-03-31 1.3 billion 494.0 million

ELAN

Price: $13.53

52 week price:
7.88
16.88

Earnings Per Share: -2.50 USD

P/E Ratio: -6.90

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 5.1 million

Market Capitalization: 7.7 billion

Links: